GS
IBB icon

GTS Securities’s iShares Biotechnology ETF IBB Stock Holding History

GTS Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-71,600
Closed -$10.4M – 2542
2024
Q3 		$10.4M Sell
71,600
-15,000
-17% -$2.17M 0.02% 493
2024
Q2 		$11.9M Buy
86,600
+6,500
+8% +$868K 0.03% 430
2024
Q1 		$11M Sell
80,100
-209,700
-72% -$28.6M 0.02% 463
2023
Q4 		$39.4M Buy
289,800
+191,800
+196% +$23.4M 0.07% 172
2023
Q3 		$12M Buy
+98,000
New +$12.5M 0.02% 529

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GTS Securities's IBB Position: Q1 2026 in Review

GTS Securities reduced its iShares Biotechnology ETF (IBB) stake by 86% in Q1 2026, selling an estimated $3.97M and leaving 3,671 shares worth $620K. The position accounts for 0.02% of the portfolio, ranked #624.

GTS Securities first reported a position in IBB in Q2 2023 and has held it in 11 quarters since. The position peaked at $9.26M in Q1 2025. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • GTS Securities held 3,671 shares of iShares Biotechnology ETF worth $620K as of Q1 2026.
  • GTS Securities sold 23,200 iShares Biotechnology ETF shares in Q1 2026, an estimated $3.97M.
  • iShares Biotechnology ETF made up 0.02% of GTS Securities's portfolio in Q1 2026, its #624 holding.
  • GTS Securities first reported a position in iShares Biotechnology ETF in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's iShares Biotechnology ETF position peaked at $9.26M in Q1 2025.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.